United States · Series B startup

Who invested in Vita Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$31Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $31MOct 2022
Investors
1
See who backed them

The rounds

  1. Oct 2022
    Series B$31M

    Source recordedSEC filing: $31M sold, first sale Oct 2022

Founders and team

From the SEC filings it signed: 1 on the team.

  • Douglas FalkExecutive Officer, Directori

On the board, as filediDavid ChurchillEva ChinJames PeyerMark NuttallVlad Coric

Everyone who backed them

TEDCOVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Vita Therapeutics

Who invested in Vita Therapeutics?

Vita Therapeutics's investors include TEDCO.

How much has Vita Therapeutics raised?

Vita Therapeutics has raised $31M across 1 round since 2022.

When did Vita Therapeutics last raise?

Vita Therapeutics's most recent round was a Series B of $31M in Oct 2022.

What was Vita Therapeutics's biggest round?

Its most recent round, $31M in Oct 2022, is also its largest on record.

Who backed Vita Therapeutics first?

Vita Therapeutics's first round on record, in Oct 2022, was backed by TEDCO.

What stage is Vita Therapeutics at?

Vita Therapeutics's latest named round is a Series B, in Oct 2022.

Where is Vita Therapeutics based?

Vita Therapeutics is based in the United States.

Companies like Vita Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.